These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38691671)

  • 1. The ketogenic diet does not improve cardiac function and blunts glucose oxidation in ischaemic heart failure.
    Ho KL; Karwi QG; Wang F; Wagg C; Zhang L; Panidarapu S; Chen B; Pherwani S; Greenwell AA; Oudit GY; Ussher JR; Lopaschuk GD
    Cardiovasc Res; 2024 Sep; 120(10):1126-1137. PubMed ID: 38691671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.
    Ho KL; Zhang L; Wagg C; Al Batran R; Gopal K; Levasseur J; Leone T; Dyck JRB; Ussher JR; Muoio DM; Kelly DP; Lopaschuk GD
    Cardiovasc Res; 2019 Sep; 115(11):1606-1616. PubMed ID: 30778524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketones can become the major fuel source for the heart but do not increase cardiac efficiency.
    Ho KL; Karwi QG; Wagg C; Zhang L; Vo K; Altamimi T; Uddin GM; Ussher JR; Lopaschuk GD
    Cardiovasc Res; 2021 Mar; 117(4):1178-1187. PubMed ID: 32402081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
    Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
    Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction.
    Sun Q; Güven B; Wagg CS; Almeida de Oliveira A; Silver H; Zhang L; Chen B; Wei K; Ketema EB; Karwi QG; Persad KL; Vu J; Wang F; Dyck JRB; Oudit GY; Lopaschuk GD
    Cardiovasc Res; 2024 Mar; 120(4):360-371. PubMed ID: 38193548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.
    Karwi QG; Zhang L; Wagg CS; Wang W; Ghandi M; Thai D; Yan H; Ussher JR; Oudit GY; Lopaschuk GD
    Cardiovasc Diabetol; 2019 Jan; 18(1):1. PubMed ID: 30626440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketones provide an extra source of fuel for the failing heart without impairing glucose oxidation.
    Pherwani S; Connolly D; Sun Q; Karwi QG; Carr M; Ho KL; Wagg CS; Zhang L; Levasseur J; Silver H; Dyck JRB; Lopaschuk GD
    Metabolism; 2024 May; 154():155818. PubMed ID: 38369056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.
    Jaswal JS; Keung W; Wang W; Ussher JR; Lopaschuk GD
    Biochim Biophys Acta; 2011 Jul; 1813(7):1333-50. PubMed ID: 21256164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Hydroxybutyrate Exacerbates Hypoxic Injury by Inhibiting HIF-1α-Dependent Glycolysis in Cardiomyocytes-Adding Fuel to the Fire?
    Ma X; Dong Z; Liu J; Ma L; Sun X; Gao R; Pan L; Zhang J; A D; An J; Hu K; Sun A; Ge J
    Cardiovasc Drugs Ther; 2022 Jun; 36(3):383-397. PubMed ID: 34652582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Energy Metabolism in Heart Failure.
    Lopaschuk GD; Karwi QG; Tian R; Wende AR; Abel ED
    Circ Res; 2021 May; 128(10):1487-1513. PubMed ID: 33983836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction.
    Fillmore N; Levasseur JL; Fukushima A; Wagg CS; Wang W; Dyck JRB; Lopaschuk GD
    Mol Med; 2018 Mar; 24(1):3. PubMed ID: 30134787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
    Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketone metabolism in the failing heart.
    Lopaschuk GD; Karwi QG; Ho KL; Pherwani S; Ketema EB
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158813. PubMed ID: 32920139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy.
    Fillmore N; Mori J; Lopaschuk GD
    Br J Pharmacol; 2014 Apr; 171(8):2080-90. PubMed ID: 24147975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
    Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Failing Heart Relies on Ketone Bodies as a Fuel.
    Aubert G; Martin OJ; Horton JL; Lai L; Vega RB; Leone TC; Koves T; Gardell SJ; Krüger M; Hoppel CL; Lewandowski ED; Crawford PA; Muoio DM; Kelly DP
    Circulation; 2016 Feb; 133(8):698-705. PubMed ID: 26819376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the interdependence of ketone body oxidation, glycogen content, glycolysis and energy metabolism in the heart.
    Kadir AA; Stubbs BJ; Chong CR; Lee H; Cole M; Carr C; Hauton D; McCullagh J; Evans RD; Clarke K
    J Physiol; 2023 Apr; 601(7):1207-1224. PubMed ID: 36799478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Chain Fatty Acids Outpace Ketone Oxidation in the Failing Heart.
    Carley AN; Maurya SK; Fasano M; Wang Y; Selzman CH; Drakos SG; Lewandowski ED
    Circulation; 2021 May; 143(18):1797-1808. PubMed ID: 33601938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Cardiac Actions of the Sodium Glucose Co-Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure-Overload Heart Failure.
    Li X; Lu Q; Qiu Y; do Carmo JM; Wang Z; da Silva AA; Mouton A; Omoto ACM; Hall ME; Li J; Hall JE
    J Am Heart Assoc; 2021 Mar; 10(6):e018298. PubMed ID: 33719499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac metabolic modulation upon low-carbohydrate low-protein ketogenic diet in diabetic rats studied in vivo using hyperpolarized
    Abdurrachim D; Teo XQ; Woo CC; Ong SY; Salleh NF; Lalic J; Tan RS; Lee PTH
    Diabetes Obes Metab; 2019 Apr; 21(4):949-960. PubMed ID: 30536560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.